Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Josie Godfrey
Observed names:
Godfrey, Josie,
J Godfrey,
J. Godfrey
Institution:
Duchenne UK
Observed institution:
Duchenne UK
ORCID:
0009-0007-9155-4795
Observed ORCID:
0009-0007-9155-4795
OpenAlex ID:
A5101478697
Developing a Natural History Model for Duchenne Muscular Dystrophy
2023
·
Jonathan Broomfield
, M. Hill
, et al.
·
PharmacoEconomics - Open
·
26
PDF
From Off-Label to Repurposed Drug in Non-Oncological Rare Diseases: Definition and State of the Art in Selected EU Countries
2017
·
Paola Minghetti
, Elena P. Lanati
, et al.
·
Medicine Access Point of Care
·
12
PDF
Epidemiology and healthcare resource utilisation associated with Duchenne muscular dystrophy
2024
·
Christopher Llewellyn Morgan
, Josie Godfrey
, et al.
·
Journal of Rare Diseases
·
8
PDF
Pb4 Project Hercules: a Patient Led Paradigm in Evidence Generation for Hta in Duchenne Muscular Dystrophy
2020
·
E. Crossley
, F. Chandler
, et al.
·
Value in Health
·
6
Understanding the health-related quality of life impacts of caring for children and adolescents with rare progressive life-limiting conditions: key challenges and future research priorities
2025
·
Philip A. Powell
, Jill Carlton
, et al.
·
Quality of Life Research
·
4
Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies
2024
·
Ione Woollacott
, Amit Chhabra
, et al.
·
BMC Health Services Research
·
4
PDF
Pro16 Project Hercules: a Case Study in Developing a Multi-company, Flexible Cost-effectiveness Model in a Rare Disease
2019
·
F. Woodcock
, J. Mumby-Croft
, et al.
·
Value in Health
·
3
Real-world durability challenges with nAMD treatments and the potential promise of gene therapy
2026
·
Marion Munk
, Frank G. Holz
, et al.
·
Current Medical Research and Opinion
·
1
Correction: Developing a Natural History Model for Duchenne Muscular Dystrophy
2024
·
Jonathan Broomfield
, M. Hill
, et al.
·
PharmacoEconomics - Open
·
1
Pnd21 Project Hercules: a New Paradigm for Patient-centred Collaboration in Hta
2019
·
E. Crossley
, F. Chandler
, et al.
·
Value in Health
·
1
PDF
Pro151 Project Hercules: a Modified Delphi Survey to Inform a Burden-of-illness Study in Duchenne Muscular Dystrophy
2019
·
J. Evans
, A. Rose
, et al.
·
Value in Health
·
1
PDF
Pro130 Project Hercules: Construction of a New Preference-based Measure of Quality of Life for Duchenne Muscular Dystrophy (dmd)
2019
·
P.A. Powell
, J. Carlton
, et al.
·
Value in Health
·
1
Pro20 Project Hercules: a Paradigm Shift in the Development of Cost-effectiveness Models in Rare Diseases
2019
·
F. Woodcock
, J. Mumby-Croft
, et al.
·
Value in Health
·
1
PDF
EP.41Project HERCULES: could international collaboration on value assessment change clinical practice?
2019
·
K. Abrams
, J. Carlton
, et al.
·
Neuromuscular Disorders
·
1
4.84eP HERCULES use of lived experience to inform a disability-based model of the cost of Duchenne muscular dystrophy (DMD)
2026
·
Emily Reuben
, Fleur Chandler
, et al.
·
Neuromuscular Disorders
Patient-Led Collaboration for HTA Tools and Evidence Development: Project HERCULES
2026
·
Emily Reuben
, Josie Godfrey
, et al.
·
Health informatics
PDF
Protocol for an eDelphi study to identify consensus on policy metrics which should be included in future assessments of the England Rare Diseases Action Plans
2025
·
Petra A Wark
, Leeza Osipenko
, et al.
·
medRxiv
PDF
HTA365 Current Methods of Assessing Health-Related Quality of Life (HRQoL) in Informal Carers of Children With Rare Progressive Life-Limiting Conditions Are Inadequate: Findings From a Collaborative Project Hercules Workshop
2024
·
J Carlton
, P Powell
, et al.
·
Value in Health
PDF
347P Project HERCULES – building an evidence base to inform clinical care and access to medicines in DMD
2024
·
J. Godfrey
, E. Reuben
, et al.
·
Neuromuscular Disorders
EE303 Distribution and Predictors of Haemophilia-Related Direct Medical Cost in the United Kingdom: Analysis of Data From the CHESS I and CHESS II Burden of Illness Studies
2022
·
A Chhabra
, I Woollacott
, et al.
·
Value in Health
PDF
PCR143 Project Hercules - Burden of Steroid Use in the Treatment of Duchenne Muscular Dystrophy: Findings From Patient and Carer Dyads and a Focus Group
2022
·
K Tolley
, J Noble-Longster
, et al.
·
Value in Health
PDF
POSA20 Project Hercules - Burden of Steroid Use in the Treatment of Duchenne Muscular Dystrophy: Findings from a Targeted Literature Review and Online Survey
2022
·
J Noble-Longster
, C Hariri
, et al.
·
Value in Health
PDF
Dmd/bmd – Outcome Measures
2021
·
J. Broomfield
, M. Hill
, et al.
·
Neuromuscular Disorders
PDF
The Impact of Payer and Reimbursement Authorities Evidence Requirements on Healthcare Solution Design for Muscular Dystrophies
2020
·
Maximilian Lebmeier
, Fleur Chandler
, et al.
·
IntechOpen eBooks
PDF
The Burden of Illness in Duchenne Muscular Dystrophy - How Much Evidence is Available?
2018
·
AJ Hatswell
, J Godfrey
, et al.
·
Value in Health
Show more works
View as search
Works count:
27
Citation count:
70
H-index:
4
I10-index:
2
Year
Topic
Type